Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rie Hyo

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid]Hiroyuki Fujita, Aya Nakaya, Jun Kato, et al.
Medical Oncology (Northwood, London, England)|June 24, 2008
Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in JapanAtsuko Fujita, Naoto Tomita, Hiroyuki Fujita, et al.
American Journal of Hematology|August 5, 2006
Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donorYoshinobu Kanda, Rie Hyo, Takuya Yamashita, et al.
Haematologica|June 19, 2009
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocationsNaoto Tomita, Mami Tokunaka, Naoya Nakamura, et al.
Blood|October 11, 2011
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal typeRitsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, et al.
Hematological Oncology|April 10, 2009
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphomaRie Hyo, Naoto Tomita, Kengo Takeuchi, et al.
International Journal of Hematology|February 19, 2011
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignanciesTakayoshi Tachibana, Masatsugu Tanaka, Hirotaka Takasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[ABVD chemotherapy for Hodgkin lymphoma at a single institute]Rika Ohshima, Shigeki Motomura, Chizuko Hashimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group studyMotoko Yamaguchi, Yok-Lam Kwong, Won Seog Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal typeYoshinori Ito, Hiroshi Kimura, Yoshinobu Maeda, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid]Hiroyuki Fujita, Aya Nakaya, Jun Kato, et al.
Medical Oncology (Northwood, London, England)|June 24, 2008
Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in JapanAtsuko Fujita, Naoto Tomita, Hiroyuki Fujita, et al.
American Journal of Hematology|August 5, 2006
Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donorYoshinobu Kanda, Rie Hyo, Takuya Yamashita, et al.
Haematologica|June 19, 2009
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocationsNaoto Tomita, Mami Tokunaka, Naoya Nakamura, et al.
Blood|October 11, 2011
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal typeRitsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, et al.
Hematological Oncology|April 10, 2009
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphomaRie Hyo, Naoto Tomita, Kengo Takeuchi, et al.
International Journal of Hematology|February 19, 2011
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignanciesTakayoshi Tachibana, Masatsugu Tanaka, Hirotaka Takasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[ABVD chemotherapy for Hodgkin lymphoma at a single institute]Rika Ohshima, Shigeki Motomura, Chizuko Hashimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group studyMotoko Yamaguchi, Yok-Lam Kwong, Won Seog Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal typeYoshinori Ito, Hiroshi Kimura, Yoshinobu Maeda, et al.
Pageof 3